Dr. Gandhi joins NextPoint from the Dana Farber Cancer Institute in Boston, according to a Feb. 21 news release. While at Dana Farber, she served as director of the Center for Cancer Therapeutic Innovation.
Dr. Gandhi has also served as vice president of immuno-oncology development at pharmaceutical company Eli Lilly and director of thoracic medical oncology at New York University.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.